Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MYLK4

RBC: MYLK4 · Substrate: DAPKtide · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Sunitinib99.10.52
Vemurafenib95.80.60
Fedratinib79.10.58
Pacritinib79.00.45
Abemaciclib67.30.56
Abrocitinib50.00.58
Nintedanib44.30.61
Midostaurin41.40.50
Netarsudil37.50.68
Ponatinib35.20.53
Selpercatinib23.60.64
Capmatinib19.70.58
Crizotinib17.70.58
Erlotinib15.80.69
Lenvatinib15.70.73

Known variants

No variants catalogued.
Open in new tab